Skip to Main Content
Try STAT+ TODAY
Trending:
STAT+
Health
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
‘They were his best shot. And they failed to…
‘They were his best shot. And they failed to help’: Why did EMS workers neglect Tyre…
Common injections don’t help knee osteoarthritis more than placebo,…
Common injections don’t help knee osteoarthritis more than placebo, large data review finds
Boston biotech internship program aims to increase diversity through…
Boston biotech internship program aims to increase diversity through expansion
Pharmalittle: AbbVie to lift $2B cap on deals as…
Pharmalittle: AbbVie to lift $2B cap on deals as Humira rivals appear; India to spend $80M…
FDA grants priority review for Sage’s rapid-acting treatment for…
FDA grants priority review for Sage’s rapid-acting treatment for depression
Eisai reports first U.S. sales of newly approved treatment…
Eisai reports first U.S. sales of newly approved treatment for Alzheimer’s disease

Recommended Stories